Pacira BioSciences to Host Investor Day on October 15th, 2021 in Tampa, FL
October 08, 2021 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences Notified of Abbreviated New Drug Application Filing for EXPAREL®
October 04, 2021 07:30 ET
|
Pacira BioSciences
TAMPA, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, has...
Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility
September 30, 2021 07:30 ET
|
Pacira BioSciences
PARSIPPANY, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions,...
Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries
September 21, 2021 07:30 ET
|
Pacira BioSciences
PARSIPPANY, N.J., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that full results of its Phase 3 PLAY study of EXPAREL® (bupivacaine liposome injectable...
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021
September 15, 2021 07:30 ET
|
Pacira BioSciences
-- Expanding EXPAREL utilization continues to drive growth with average daily sales at 109% of August 2020 -- -- More than nine million patients treated with EXPAREL as of August 2021 -- PARSIPPANY,...
Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021 08:00 ET
|
Pacira BioSciences
PARSIPPANY, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the H.C. Wainwright 23rd Annual Global Investment Conference at...
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021
August 10, 2021 08:00 ET
|
Pacira BioSciences
PARSIPPANY, N.J., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions,...
Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference
August 04, 2021 08:00 ET
|
Pacira BioSciences
PARSIPPANY, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Wedbush PacGrow Healthcare Virtual Conference at 10:20 AM...
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
August 03, 2021 08:00 ET
|
Pacira BioSciences
-- EXPAREL average daily sales at 178% of the prior year second quarter ---- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc....
Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process
August 02, 2021 08:00 ET
|
Pacira BioSciences
-- New 200-liter suite doubles capacity to meet growing EXPAREL demand -- -- Patent covering enhanced manufacturing process extends proprietary position to January 2041 -- PARSIPPANY, N.J., Aug. ...